The company’s loss from operations for the second quarter of 2011 was $364,000, compared to $1.97m for the same period in 2010.
For the six months ended 30 June 2011, the company reported a net loss of $1.91m, compared to $3.14m for the same period in 2010.
Cortex Pharma’s operating loss was $1.92m for the six months of 2011, compared to $3.14m for the same period in 2010.